AOL Inc. (NYSE:AOL)’s Chairman and CEO Tim Armstrong participated in the Deutsche Bank Media, Internet and Telecom Conference on Mar. 10, 2015, at The Breakers in Palm Beach, Florida. Armstrong’s presentation began at approximately 10:05 AM Eastern Time (ET). On Thursday shares of AOL Inc. (NYSE:AOL) closed at $39.50. Company’s sales growth for last 5 years was -4.90% and EPS growth for next 5 years is recorded as 9.53%.
Coastal Automotive LLC said Tuesday it signed a licensing agreement with the automotive division of The Dow Chemical Company (NYSE:DOW) for automotive foam technology. Coastal will manufacture Dow’s sound mitigation polymer foam technology and supply it to its automotive customers, the company said in a press release. The Dow Chemical Company (NYSE:DOW) in last trading activity increased 1.45% to close at $47.46. Company weekly performance is -2.92% while its quarterly performance stands at -0.59%. The Dow Chemical Company (NYSE:DOW) is -12.26% away from its 52 week high.
Alcoa Inc. (NYSE:AA) has announced the signing of a definitive agreement to acquire RTI International Metals, Inc., a global supplier of titanium and specialty metal products and services for the commercial aerospace, defense, energy and medical device markets. Alcoa will purchase RTI in a stock-for-stock transaction with an enterprise value of $1.5 billion. Alcoa Inc. (NYSE:AA) in last trading activity moved up 1.55% to close at $13.80. Company weekly performance is -4.03% while its quarterly performance stands at -13.80%. Alcoa Inc. (NYSE:AA) is -22.12% away from its 52 week high.
On March 2, Aerie Pharmaceuticals Inc. (NASDAQ:AERI) reported a net loss of $48.1 million, or $2 per share, for the full-year 2014, according to a press release. For the fourth quarter 2014, there was a net loss of $16.5 million, or $0.69 per share, compared with a net loss of $10.3 million, or $0.62 per share, for the fourth quarter 2013. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has 2.70% insider ownership while its institutional ownership stands at 95.30%. In last trading activity company’s stock closed at $28.94.
Mindray Medical International Limited (NYSE:MR) had its price objective decreased by JMP Securities from $23.00 to $22.00 in a research report released on Wednesday morning. JMP Securities currently has a market underperform rating on the stock. On last trading day Mindray Medical International Limited (NYSE:MR) increased 1.89% to close at $28.03. Its volatility for the week is 3.93% while volatility for the month is 3.41%. MR’s sales growth for past 5 years was 17.30% and its EPS growth for past 5 years was 14.30%. Mindray Medical International Limited (NYSE:MR) monthly performance is 2.26%.